Biodexa Shares Are Trading Higher After the Company Entered an Exclusive License Agreement With Rapamycin Holdings for the Rights to ERapa
Biodexa与雷帕霉素控股公司签订了eRapa权利的独家许可协议后,该公司股价走高
Biodexa Shares Are Trading Higher After the Company Entered an Exclusive License Agreement With Rapamycin Holdings for the Rights to ERapa
Biodexa与雷帕霉素控股公司签订了eRapa权利的独家许可协议后,该公司股价走高
使用浏览器的分享功能,分享给你的好友吧